News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Elekta’s Interim Report May-July 2010/11
September 8, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
STOCKHOLM--(BUSINESS WIRE)--Elekta’s interim report for the first three months 2010/11 will be published on September 21, 2010 with the following schedule:
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Deals
AbbVie bets up to $1.47B for Nxera’s discarded IBD program
November 4, 2026
·
2 min read
·
Gabrielle Masson
Earnings
Amgen starts MariTide autoinjector study as pivotal readouts approach
November 4, 2026
·
2 min read
·
Nick Paul Taylor
Drug pricing
With MFN now embedded in pharma, execs see little impact from Democrats’ blue wave
November 4, 2026
·
4 min read
·
Annalee Armstrong
Weight loss
Novo, Lilly battle for oral GLP-1 dominance with data tit for tat
November 4, 2026
·
3 min read
·
Annalee Armstrong
